Newron Pharmaceuticals
NWRN.SW
#8287
Rank
NZ$0.30 B
Marketcap
$15.92
Share price
-0.74%
Change (1 day)
93.88%
Change (1 year)

Newron Pharmaceuticals (NWRN.SW) - Total debt

Total debt on the balance sheet as of December 2023 : NZ$94.58 Million

According to Newron Pharmaceuticals's latest financial reports the company's total debt is NZ$94.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Newron Pharmaceuticals - Total debt on balance sheet (from 2009 to 2023)

Total debt by year

Year Total debt Change
2023-12-31NZ$84.63 M9.7%
2022-12-31NZ$77.14 M8%
2021-12-31NZ$71.42 M59.05%
2020-12-31NZ$44.9 M59.88%
2019-12-31NZ$28.08 M5867.3%
2018-12-31NZ$0.47 M
2017-12-31N/A-100%
2016-12-31NZ$0.55 M-52.34%
2015-12-31NZ$1.15 M-31.26%
2014-12-31NZ$1.68 M-30.52%
2013-12-31NZ$2.42 M-16.19%
2012-12-31NZ$2.89 M-19.27%
2011-12-31NZ$3.58 M
2010-12-31N/A-100%
2009-12-31NZ$0.55 M-74.69%
2008-12-31NZ$2.18 M37.91%
2007-12-31NZ$1.58 M-23.28%
2006-12-31NZ$2.06 M15.15%
2005-12-31NZ$1.79 M